By Ovid Therapeutics
To listen to an audio podcast, mouse over the title and click Play. Open iTunes to download and subscribe to podcasts.
Ovid Therapeutics is a company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Hosted by Amit Rakhit, MD, MBA, this is our podcast. This is Bold Medicine.
||CleanThe Cute Syndrome Foundation||Amit talks with Hillary Savoie, Founder of The Cute Syndrome Foundation. Hillary shares her journey as a parent and rare epilepsy community leader.||3/21/2018||Free||View in iTunes|
||CleanWelcome to Ovid||In the first episode we introduce our host, Dr. Amit Rakhit, MD, MBA. Amit talks about the core philosophy that makes Ovid Therapeutics different in our approach. Amit also shares a remarkable story that inspires him to come to work every single day --.||2/7/2018||Free||View in iTunes|
||CleanWhy We Do What We Do||Amit introduces Chief Scientific Officer and Founder, Matthew During, M.D., D.Sc., and core members of the Ovid Research team. Matt, Melanie, Toshiya, and Amit talk about the diverse science-driven Ovid family,||2/5/2018||Free||View in iTunes|
||CleanLennox-Gastaut Syndrome||Founder of the Lennox-Gastaut Syndrome Foundation, Christina Sanlnocecio, talks about innovative programs available for LGS patients and families. This incredible foundation is driving science and supporting every patient and family affected by Lennox-.||2/5/2018||Free||View in iTunes|
||CleanChelsea Leyland||Chelsea Leyland shares her story of growing up with Juvenile Myclonic Epilepsy. Chelsea talks about her battle with rare epilepsy and the need to remove stigmas attached to the disease. In this episode we talk about what it's like to watch a loved one .||2/5/2018||Free||View in iTunes|
||CleanNORD Summit and Dr. Google||A hot topic at this year's National Organization for Rare Disorders (NORD) Summit was patient access to medication. In our patient-centric quick fire challenge, Amit tells us about the perfect patient partner.||2/5/2018||Free||View in iTunes|
Get to know a new type pharma company
The tide is turning and innovators are having their day as pharma is earning a new reputation that is patient centric. I appreciated the candor and access to the CMO and his ability to communicate what is truly important and possible when putting the patient first. Hope more pharma companies become this transparent...